FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nadia Belaïdouni

Research Profile

Chemicals & Drugs

Living Beings

HIV-1

Anatomy

Physiology

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Frédéric Pène; Christophe Rousseau; Bertrand Sauneuf; Benjamin Zuber; Carole El Hachem; David Grimaldi; Clémence Martin; Jean-Paul Mira; Viviane Balloy; Nadia Belaïdouni; Jean-Daniel Chiche
Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
Erwann Le Rouzic; Marina Morel; Diana Ayinde; Nadia Belaïdouni; Justine Letienne; Catherine transy; Florence Margottin-Goguet
Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
Emilie Estrabaud; Erwann Le Rouzic; Sandra Lopez-Vergès; Marina Morel; Nadia Belaïdouni; Richard Benarous; Catherine transy; Clarisse Berlioz-Torrent; Florence Margottin-Goguet
Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nadia Belaïdouni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Frédéric Pène; Christophe Rousseau; Bertrand Sauneuf; Benjamin Zuber; Carole El Hachem; David Grimaldi; Clémence Martin; Jean-Paul Mira; Viviane Balloy; Nadia Belaïdouni; Jean-Daniel Chiche
Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction.
The Journal of infectious diseases 2012;206(6):932-42.
2008: Erwann Le Rouzic; Marina Morel; Diana Ayinde; Nadia Belaïdouni; Justine Letienne; Catherine transy; Florence Margottin-Goguet
Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.
The Journal of biological chemistry 2008;283(31):21686-92.
2007: Emilie Estrabaud; Erwann Le Rouzic; Sandra Lopez-Vergès; Marina Morel; Nadia Belaïdouni; Richard Benarous; Catherine transy; Clarisse Berlioz-Torrent; Florence Margottin-Goguet
Regulated degradation of the HIV-1 Vpu protein through a betaTrCP-independent pathway limits the release of viral particles.
PLoS pathogens 2007;3(7):e104.
2007: Nadia Belaïdouni; Christelle Marchal; Richard Benarous; Corinne Besnard-Guérin
Involvement of the betaTrCP in the ubiquitination and stability of the HIV-1 Vpu protein.
Biochemical and biophysical research communications 2007;357(3):688-93.
2007: Erwann Le Rouzic; Nadia Belaïdouni; Emilie Estrabaud; Marina Morel; Jean-Christophe Rain; Catherine transy; Florence Margottin-Goguet
HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
Cell cycle (Georgetown, Tex.) 2007;6(2):182-8.
2005: Nadia Belaïdouni; Michel Peuchmaur; Christine Perret; Agnès Florentin; Richard Benarous; Corinne Besnard-Guérin
Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice.
Oncogene 2005;24(13):2271-6.
2004: Corinne Besnard-Guerin; Nadia Belaïdouni; Irina Lassot; Emmanuel Segeral; Aude Jobart; Christelle Marchal; Richard Benarous
HIV-1 Vpu sequesters beta-transducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates.
The Journal of biological chemistry 2004;279(1):788-95.